Dr Erik A.M. Briers MS PhD

President

Europa Uomo

Erik Briers holds a doctorate in Science - Chemistry from the University of Leuven, Belgium. Since his promotion in 1979 he has been involved in laboratory medicine.

He founded in 1982 the diagnostic company Eco-Bio diagnostics and served as its CEO until 1990. In this function he developed a diagnostic test for the detection of Aspergillus antigens with a fast assay allowing the potential curative treatment of patients with disseminated aspergillosis, a deadly disease. This test has been approved by the FDA.

He has been a guest lecturer for the subject “Applied immunology” within the Master study programme Biochemical Engineering at the University of Leuven 2009-2016.

Erik Briers was the Executive Director of the European Cancer Patient Coalition (ECPC) (2012-2013) and ad interim executive director of EPPOSI (The European Platform for Patient Organizations Science and Industry) (2014).

He was active at the European Medicine Agency (EMA) at the Patient and Consumer working party (PCWP) and later was appointed by the EU commission as an alternate patient member of the Committee on Advanced Therapies (CAT) (2016-2019).

He is board member and chairman of Europa Uomo (European Prostate Cancer Coalition).

He is a member of the Guidelines Panel on the treatment of prostate cancer of the European Association of Urology (EAU) since 2013.

He is since 2013 member of the patient advisory board of the European Society of Radiology (ESR-PAG) and has given many presentations at the occasion of the yearly European Congress of Radiology (ECR).

He is vice-president of Us Too Belgium and the chief editor of PROSTAATinfo the magazine of the organization.

He serves as a member of advisory boards of several scientific organizations.

The European Association of Urology awarded him the “2024 Medal of excellence in Patient Advocacy” on the occasion of the EAU congress in Paris 2024.

Updated: January 2026